Biggest News Aggregation in the World
📰 Aldx News

Aldx News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Aldx. Real-time updates on events, politics, business and more.

Aldeyra Therapeutics (NASDAQ:ALDX) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a sell rating to a hold rating in a research report released on Tuesday morning. Several other equities analysts have also commented on the company. HC Wainwright reiterated a buy rating and issued a $10.00 target price on shares of Aldeyra Therapeutics in a […]
Los Angeles United States Bruce Greenberg Securities Exchange Commission Jacobs Levy Equity Management Inc Acadian Asset Management

Perceptive Advisors Llc Buys 37,712 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Stock

Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Free Report) major shareholder Perceptive Advisors Llc acquired 37,712 shares of the firm’s stock in a transaction that occurred on Friday, April 5th. The shares were bought at an average price of $4.74 per share, with a total value of $178,754.88. Following the acquisition, the insider now directly owns […]
Sg Americas Securities Capital Investment Advisors Perceptive Advisors Llc Ameritas Investment Partners Inc Northrock Partners Tower Research Capital

Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Major Shareholder Acquires $27,215.50 in Stock

Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Free Report) major shareholder Perceptive Advisors Llc acquired 8,374 shares of the stock in a transaction that occurred on Monday, April 1st. The shares were bought at an average cost of $3.25 per share, for a total transaction of $27,215.50. Following the completion of the transaction, the insider now […]
Ameritas Investment Partners Inc Northrock Partners Perceptive Advisors Llc Sg Americas Securities Aldeyra Therapeutics Company Profile Aldeyra Therapeutics Inc
Source: wkrb13.com

Insider Selling: Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Insider Sells 13,201 Shares of Stock

Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Free Report) insider Bruce Greenberg sold 13,201 shares of Aldeyra Therapeutics stock in a transaction that occurred on Monday, March 11th. The shares were sold at an average price of $3.41, for a total transaction of $45,015.41. Following the sale, the insider now directly owns 120,699 shares in the […]
Bruce Greenberg Tower Research Capital Cubist Systematic Strategies Aldeyra Therapeutics Inc Ameritas Investment Partners Inc Aldeyra Therapeutics

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Perceptive Advisors Llc Sells 2,450,000 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Stock

Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Free Report) major shareholder Perceptive Advisors Llc sold 2,450,000 shares of Aldeyra Therapeutics stock in a transaction on Monday, October 16th. The stock was sold at an average price of $1.60, for a total value of $3,920,000.00. Following the completion of the transaction, the insider now owns 8,900,085 shares […]
Goldman Sachs Group Inc Aldeyra Therapeutics Inc Blackrock Inc Perceptive Advisors Llc Knoll Capital Management Aldeyra Therapeutics

Aldeyra Therapeutics Falls After FDA Indicated Addl. Clinical Trial For Reproxalap For Dry Eye

Aldeyra Therapeutics, Inc. (ALDX) shares are falling more than 58 percent on Monday morning trade after the company announced that the FDA, in a review related to its new drug application for Reproxalap for dry eye disease, opined that the data is not supporting the clinical relevance of the ocular signs to support dry eye indication.
Aldeyra Therapeutics Inc Aldeyra Therapeutics Prescription Drug User Fee Act Stock Alert Aldeyra Therapeutics

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science